Cite
Schuster DM, Taleghani PA, Nieh PT, et al. Characterization of primary prostate carcinoma by anti-1-amino-2-[(18)F] -fluorocyclobutane-1-carboxylic acid (anti-3-[(18)F] FACBC) uptake. Am J Nucl Med Mol Imaging. 2013;3(1):85-96
Schuster, D. M., Taleghani, P. A., Nieh, P. T., Master, V. A., Amzat, R., Savir-Baruch, B., Halkar, R. K., Fox, T., Osunkoya, A. O., Moreno, C. S., Nye, J. A., Yu, W., Fei, B., Wang, Z., Chen, Z., & Goodman, M. M. (2013). Characterization of primary prostate carcinoma by anti-1-amino-2-[(18)F] -fluorocyclobutane-1-carboxylic acid (anti-3-[(18)F] FACBC) uptake. American journal of nuclear medicine and molecular imaging, 3(1), 85-96.
Schuster, David M, et al. "Characterization of primary prostate carcinoma by anti-1-amino-2-[(18)F] -fluorocyclobutane-1-carboxylic acid (anti-3-[(18)F] FACBC) uptake." American journal of nuclear medicine and molecular imaging vol. 3,1 (2013): 85-96.
Schuster DM, Taleghani PA, Nieh PT, Master VA, Amzat R, Savir-Baruch B, Halkar RK, Fox T, Osunkoya AO, Moreno CS, Nye JA, Yu W, Fei B, Wang Z, Chen Z, Goodman MM. Characterization of primary prostate carcinoma by anti-1-amino-2-[(18)F] -fluorocyclobutane-1-carboxylic acid (anti-3-[(18)F] FACBC) uptake. Am J Nucl Med Mol Imaging. 2013;3(1):85-96. Epub 2013 Jan 05. PMID: 23342303; PMCID: PMC3545368.
Copy
Download .nbib